Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Treasury Shares: 2013-2024

Historic Treasury Shares for Ani Pharmaceuticals (ANIP) over the last 9 years, with Dec 2024 value amounting to $21.0 million.

  • Ani Pharmaceuticals' Treasury Shares rose 207.91% to $32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.6 million, marking a year-over-year increase of 207.91%. This contributed to the annual value of $21.0 million for FY2024, which is 108.71% up from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Treasury Shares is $21.0 million, which was up 108.71% from $10.1 million recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Treasury Shares peaked at $1.4 million during FY2023, and registered a low of $352,000 during FY2020.
  • Over the past 3 years, Ani Pharmaceuticals' median Treasury Shares value was $1.1 million (recorded in 2022), while the average stood at $973,852.
  • Data for Ani Pharmaceuticals' Treasury Shares shows a peak YoY skyrocketed of 210.65% (in 2020) over the last 5 years.
  • Over the past 5 years, Ani Pharmaceuticals' Treasury Shares (Yearly) stood at $2.2 million in 2020, then spiked by 39.58% to $3.1 million in 2021, then soared by 62.49% to $5.1 million in 2022, then spiked by 97.90% to $10.1 million in 2023, then spiked by 108.71% to $21.0 million in 2024.